P

Inventor

CHEN GUODONG

US74 patents
⚠️ This page may combine multiple inventors who share the name “CHEN GUODONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

36 patents
US9228016B2Jan 5, 2016

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BRISTOL MYERS SQUIBB CO85 citations98
US10100129B2Oct 16, 2018

Antibodies against CD73 and uses thereof

BRISTOL MYERS SQUIBB CO24 citations93
US9605080B2Mar 28, 2017

Antibodies against CD73

BRISTOL MYERS SQUIBB CO31 citations93
US10465010B2Nov 5, 2019

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BRISTOL MYERS SQUIBB CO9 citations92
US9745379B2Aug 29, 2017

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BRISTOL MYERS SQUIBB CO11 citations92
US8945553B2Feb 3, 2015

Bispecific antibodies to IL-23 and IL-17A/F

BRISTOL MYERS SQUIBB CO16 citations91
US11084881B2Aug 10, 2021

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BRISTOL MYERS SQUIBB CO3 citations84
US10501550B2Dec 10, 2019

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BRISTOL MYERS SQUIBB CO9 citations84
US10968279B2Apr 6, 2021

TL1A antibodies and uses thereof

BRISTOL MYERS SQUIBB CO6 citations82
US10533052B2Jan 14, 2020

Antibodies against TIM3 and uses thereof

BRISTOL MYERS SQUIBB CO4 citations82
US10077306B2Sep 18, 2018

Antibodies against TIM3 and uses thereof

BRISTOL MYERS SQUIBB CO7 citations82
US11008395B2May 18, 2021

Antibodies against IL-7R alpha subunit and uses thereof

BRISTOL MYERS SQUIBB CO5 citations79
US12312403B2May 27, 2025

Antibodies against TIM3 and uses thereof

BRISTOL MYERS SQUIBB CO1 citations73
US11213586B2Jan 4, 2022

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)

BRISTOL MYERS SQUIBB CO5 citations72
US11767364B2Sep 26, 2023

TL1A antibodies and methods of treatment

BRISTOL MYERS SQUIBB CO4 citations71
US11591392B2Feb 28, 2023

Antibodies against TIM3 and uses thereof

BRISTOL MYERS SQUIBB CO1 citations71
US10690674B2Jun 23, 2020

Anti-GITR antibodies for cancer diagnostics

BRISTOL MYERS SQUIBB CO5 citations71
US10167343B2Jan 1, 2019

Antibodies against CD73

BRISTOL MYERS SQUIBB CO3 citations71
US11524992B2Dec 13, 2022

Glypican-3-binding fibronectin based scaffold molecules

BRISTOL MYERS SQUIBB CO2 citations70
US10584160B2Mar 10, 2020

Glypican-3-binding fibronectin based scaffold molecules

BRISTOL MYERS SQUIBB CO3 citations70
US12077584B2Sep 3, 2024

Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A)

BRISTOL MYERS SQUIBB CO1 citations69
US11919954B2Mar 5, 2024

Anti-TREM-1 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO1 citations69
US11274150B2Mar 15, 2022

Anti-human natural killer cell inhibitory receptor group 2A protein (NKG2A) antibodies

BRISTOL MYERS SQUIBB CO2 citations69
US11155618B2Oct 26, 2021

Anti-TREM-1 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO1 citations69
US10556948B2Feb 11, 2020

IP-10 antibodies and their uses

BRISTOL MYERS SQUIBB CO2 citations69
US11242393B2Feb 8, 2022

Antibodies against MICA and/or MICB and uses thereof

BRISTOL MYERS SQUIBB CO3 citations67
US12110337B2Oct 8, 2024

Anti-CD27 antibodies and uses thereof

BRISTOL MYERS SQUIBB CO0 citations62
US11802162B2Oct 31, 2023

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

BRISTOL MYERS SQUIBB CO0 citations62
US11408889B2Aug 9, 2022

Anti-GITR antibodies for cancer diagnostics

BRISTOL MYERS SQUIBB CO1 citations61
US11352440B2Jun 7, 2022

Antibodies against CD73 and uses thereof

BRISTOL MYERS SQUIBB CO0 citations61
US9783606B2Oct 10, 2017

Polynucleotides encoding IL-17/IL-23 bispecific, IL-17A/F and IL-23p19 antibodies

BRISTOL MYERS SQUIBB CO1 citations61
US12492238B2Dec 9, 2025

Glypican-3-binding fibronectin based scaffold molecules

BRISTOL MYERS SQUIBB CO0 citations59
US11981734B2May 14, 2024

Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A)

BRISTOL MYERS SQUIBB CO0 citations59
US11952420B2Apr 9, 2024

Nucleic acids encoding anti-TREM-1 antibodies

BRISTOL MYERS SQUIBB CO0 citations59
US11919962B2Mar 5, 2024

Antibodies against IL-7R alpha subunit and uses thereof

BRISTOL MYERS SQUIBB CO0 citations58
US11708405B2Jul 25, 2023

IP-10 antibodies and their uses

BRISTOL MYERS SQUIBB CO1 citations58

CONTEMPORARY AMPEREX TECHNOLOGY CO LTD

4 patents

FIVE PRIME THERAPEUTICS INC

4 patents

CONTEMPORARY AMPEREX TECHNOLOGY HONG KONG LTD

2 patents

DELPHI TECH INC

1 patent

BEIJING NAURA MICROELECTRONICS EQUIPMENT CO LTD

1 patent

ORACLE INT CORP

1 patent

CONTEMPORARY AMPEREX TECH HONG KONG LIMITED

1 patent

Showing the top 50 of 74 patents by PatentIndex Score.